# Evaluate the Efficacy &Safety of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD

> **NCT00499863** · PHASE3 · COMPLETED · sponsor: **Noven Therapeutics** · enrollment: 217 (actual)

## Conditions studied

- ADHD

## Interventions

- **DRUG:** methylphenidate transdermal system
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00499863
- **Lead sponsor:** Noven Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 217 (ACTUAL)
- **Last updated:** 2017-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00499863

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00499863, "Evaluate the Efficacy &Safety of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT00499863. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*